Publicaciones en las que colabora con Juan Rigoberto Tejedo Huaman (23)

2023

  1. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  2. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

  3. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses

    Frontiers in Cell and Developmental Biology, Vol. 11

2022

  1. Considerations for Clinical Use of Mesenchymal Stromal Cells

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 51-102

  2. Pdx1 Is Transcriptionally Regulated by EGR-1 during Nitric Oxide-Induced Endoderm Differentiation of Mouse Embryonic Stem Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

2021

  1. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

  2. Stemness of human pluripotent cells: Hypoxia-like response induced by low nitric oxide

    Antioxidants, Vol. 10, Núm. 9

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

  2. Stem Cells: Concept, Properties, and Characterization

    CORNEAL REGENERATION: THERAPY AND SURGERY (SPRINGER INTERNATIONAL PUBLISHING AG), pp. 41-55

2017

  1. Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. Differentiation of mouse embryonic stem cells toward functional pancreatic β-cell surrogates through epigenetic regulation of Pdx1 by nitric oxide

    Cell Transplantation, Vol. 25, Núm. 10, pp. 1879-1892

  2. Nitric Oxide Prevents Mouse Embryonic Stem Cell Differentiation Through Regulation of Gene Expression, Cell Signaling, and Control of Cell Proliferation

    Journal of Cellular Biochemistry, pp. 2078-2088

2015

  1. Using stem cells to produce insulin

    Expert Opinion on Biological Therapy, Vol. 15, Núm. 10, pp. 1469-1489

2014

  1. Transient downregulation of nanog and oct4 induced by DETA/NO exposure in mouse embryonic stem cells leads to mesodermal/endodermal lineage differentiation

    Stem Cells International, Vol. 2014

2013

  1. Regulación de la Expresión del Factor de Transcripción Pdx1 por Altas Concentraciones de Óxido Nítrico en Células Madre Embrionarias de Ratón

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 2

  2. Zebularine regulates early stages of mESC differentiation: Effect on cardiac commitment

    Cell Death and Disease, Vol. 4, Núm. 4

2010

  1. Low concentrations of nitric oxide delay the differentiation of embryonic stem cells and promote their survival

    Cell Death and Disease, Vol. 1, Núm. 10

  2. Nitric oxide repression of Nanog promotes mouse embryonic stem cell differentiation

    Cell Death and Differentiation, Vol. 17, Núm. 6, pp. 1025-1033

2008

  1. Cell therapy for diabetes mellitus: An opportunity for stem cells?

    Cells Tissues Organs